MESOBLAST LTD Quarterly Research And Development Expense in USD from Q4 2017 to Q2 2023

Taxonomy & unit: ifrs-full: USD
Summary: Mesoblast Ltd quarterly/annual Research And Development Expense history and growth rate from Q4 2017 to Q2 2023.
Mesoblast Ltd Research And Development Expense for the quarter ending June 30, 2023 was $6.7M, a 32.9% increase year-over-year.
Mesoblast Ltd Research And Development Expense for the twelve months ending June 30, 2023 was $27.2M, a 17.1% decline year-over-year.
Mesoblast Ltd annual Research And Development Expense for 2023 was $27.2M, a 17.1% decline from 2022.
Mesoblast Ltd annual Research And Development Expense for 2022 was $32.8M, a 38.1% decline from 2021.
Mesoblast Ltd annual Research And Development Expense for 2021 was $53M, a 5.65% decline from 2020.

Research And Development Expense, Trailing 12 Months (USD)

Research And Development Expense, Quarterly (USD)

Research And Development Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2023	$27.2M	$6.7M	+$1.66M	+32.9%	Apr 1, 2023	Jun 30, 2023	20-F	2023-08-31
Q1 2023	$25.5M	$7.07M	-$1.18M	-14.4%	Jan 1, 2023	Mar 31, 2023	6-K	2023-05-26
Q4 2022	$26.7M	$7.68M	-$2.52M	-24.7%	Oct 1, 2022	Dec 31, 2022	6-K	2023-02-28
Q3 2022	$29.2M	$5.74M	-$3.58M	-38.4%	Jul 1, 2022	Sep 30, 2022	6-K	2022-11-28
Q2 2022	$32.8M	$5.04M	-$2.02M	-28.6%	Apr 1, 2022	Jun 30, 2022	20-F	2023-08-31
Q1 2022	$34.8M	$8.25M	-$4.19M	-33.7%	Jan 1, 2022	Mar 31, 2022	6-K	2023-05-26
Q4 2021	$39M	$10.2M	-$4.04M	-28.4%	Oct 1, 2021	Dec 31, 2021	6-K	2023-02-28
Q3 2021	$43.1M	$9.33M	-$9.95M	-51.6%	Jul 1, 2021	Sep 30, 2021	6-K	2022-11-28
Q2 2021	$53M	$7.06M	-$8.21M	-53.8%	Apr 1, 2021	Jun 30, 2021	20-F	2023-08-31
Q1 2021	$61.2M	$12.4M	-$1.94M	-13.5%	Jan 1, 2021	Mar 31, 2021	6-K	2022-06-03
Q4 2020	$63.2M	$14.2M	+$84K	+0.59%	Oct 1, 2020	Dec 31, 2020	6-K	2022-02-25
Q3 2020	$63.1M	$19.3M	+$6.89M	+55.6%	Jul 1, 2020	Sep 30, 2020	6-K	2021-11-24
Q2 2020	$56.2M	$15.3M	+$3.84M	+33.5%	Apr 1, 2020	Jun 30, 2020	20-F	2022-08-31
Q1 2020	$52.4M	$14.4M	-$28K	-0.19%	Jan 1, 2020	Mar 31, 2020	6-K	2021-06-04
Q4 2019	$52.4M	$14.2M	-$1.33M	-8.61%	Oct 1, 2019	Dec 31, 2019	6-K	2021-03-02
Q3 2019	$53.7M	$12.4M	-$6.1M	-33%	Jul 1, 2019	Sep 30, 2019	6-K	2020-11-23
Q2 2019	$59.8M	$11.4M			Apr 1, 2019	Jun 30, 2019	20-F	2021-08-31
Q1 2019		$14.4M	-$2.39M	-14.2%	Jan 1, 2019	Mar 31, 2019	6-K	2020-05-29
Q4 2018		$15.5M	-$734K	-4.53%	Oct 1, 2018	Dec 31, 2018	6-K	2020-02-28
Q3 2018		$18.5M			Jul 1, 2018	Sep 30, 2018	6-K	2019-11-27
Q1 2018		$16.8M			Jan 1, 2018	Mar 31, 2018	6-K	2019-06-03
Q4 2017		$16.2M			Oct 1, 2017	Dec 31, 2017	6-K	2019-02-22

* An asterisk sign (*) next to the value indicates that the value is likely invalid.